Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market plan focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. The company's reportable segment are; Pharmaceutical & Bio-pharmaceutical.
Company address
Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, 560
Chairman of the Board/Director/Founder/Managing Director
63 yrs
FAQs
How to Buy Strides Pharma Science Ltd Stock?
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Strides Pharma Science Ltd or scroll over to Strides Pharma Science Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Strides Pharma Science Ltd?
The share price of Strides Pharma Science Ltd stocks is ₹650.80 as on 27/04/2025
What is the Market Cap of Strides Pharma Science Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Strides Pharma Science Ltd stock is ₹5,997.9 Cr on 27/04/2025.
In which sector / industry does Strides Pharma Science Ltd operate?
Strides Pharma Science Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Strides Pharma Science Ltd?
The revenue of Strides Pharma Science Ltd as of 2023 was ₹3,891.0 Cr
What is the PE ratio of Strides Pharma Science Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Strides Pharma Science Ltd is
17.44 as on 27/04/2025.
What is the 52 week high price of Strides Pharma Science Ltd?
The 52 week high of Strides Pharma Science Ltd stock is ₹785.85.
What is the 52 week low price of Strides Pharma Science Ltd?
The 52 week low of Strides Pharma Science Ltd stock is ₹288.26.
Can fractional shares of Strides Pharma Science Ltd be purchased?
No, you cannot buy fractional shares of Strides Pharma Science Ltd, or any listed Indian company as of now.